“…[8,9] Remarkable exceptions come from the impressive work of Professor Yudin and his research group, which, over the last few years, exploited various borylated reagents [10,11] and, in particular, both αand βamino boronic acids, [12][13][14] even coming to the discovery of boron-based peptidomimetics endowed with relevant biolog-ical activities. [7,[15][16] Quite recently, from the same group, amidoboronic acid-containing peptidomimetics with constrained backbone were also achieved, and successfully demonstrated as novel VIM-2 metallo-β-lactamase inhibitors [17] (Figure 1).…”